Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Women with obesity who participate in weight loss programmes before starting in vitro fertilisation (IVF) are 47% more likely to conceive naturally than those receiving minimal or no weight loss support, according to the most comprehensive systematic review of the evidence to date.

newborn baby and mother © Getty Images (FatCamera)

The University of Oxford-led research, funded by the National Institute for Health and Care Research, analysed 12 international trials involving 1,921 women. Beyond the increase in natural conception, the study found weight loss interventions increased the odds of any pregnancy (naturally or by IVF) by 21%.

The findings, published in the Annals of Internal Medicine, are particularly significant as NHS commissioning bodies across England restrict access to NHS-funded IVF for women with a Body Mass Index (BMI) over 30. The study suggests that providing structured weight loss support could not only help women become eligible for NHS-funded treatment but may also increase their chances of conceiving without medical assistance.

Dr Moscho Michalopoulou, lead author from Oxford’s Nuffield Department of Primary Care Health Sciences, said: 'Currently, women with obesity can face a double challenge with higher rates of infertility and potential exclusion from NHS-funded IVF. Our findings offer hope. They suggest that offering structured weight loss support could improve the chance of conceiving naturally, which may avoid the need for IVF treatment. Programmes that help women achieve greater weight losses have the potential to help more women achieve a successful outcome, and should be tested in larger high-quality trials.'

The review synthesised evidence from a wide range of interventions, including diet programmes, exercise, and weight loss medications such as orlistat (which reduces fat absorption) and older GLP-1 agonists - earlier versions of the drug class that now includes Ozempic and Wegovy. On average, women in the intervention groups lost 4kg more than those in the comparison groups.

 

Read the full story on the University of Oxford website.

 

Similar stories

Exceptional early-career researchers awarded 2026 European Research Council Starting Grants

Four University of Oxford researchers have been awarded prestigious European Research Council (ERC) Starting Grants, each worth €1.5 million for a period of up to five year

How body fat is stored across organs may reveal hidden health risks, study suggests

Researchers from the Nuffield Department of Population Health and the University of Oxford’s Big Data Institute have contributed to a new study showing that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.

Four Oxford researchers recognised in the 2026 Royal Society Awards

The annual Royal Society Awards recognise outstanding contributions to scientific discovery, public engagement and research culture. Of the 27 awards for 2025-26, announced today, four honour Oxford University researchers.

New shingles vaccine linked to lower risk of coronary heart disease, stroke and heart failure – major study indicates

The shingles vaccine currently in use, called ‘Shingrix’, is associated with a reduced risk of cardiovascular events – including heart attacks, heart failure and stroke – compared to the previous shingles vaccine, according to a major new study published in Nature Medicine.

Vapes help more people quit smoking than other methods, Oxford-led Cochrane review finds

An updated Cochrane review led by Oxford researchers finds nicotine e-cigarettes help more people quit smoking than nicotine patches and gum, behavioural support or no support. The living review now includes 80 trials and nearly 30,000 participants.

Brain imaging study reveals how we decide whether we are in control

A brain imaging and stimulation study led by the University of Oxford has identified the brain mechanisms that help us work out whether the consequences we experience are caused by our own actions or by circumstances beyond our control.